News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,391 Results
Type
Article (3783)
Company Profile (16)
Press Release (65592)
Section
Business (21062)
Career Advice (942)
Deals (3804)
Drug Delivery (9)
Drug Development (8064)
Employer Resources (42)
FDA (1703)
Job Trends (1984)
News (35740)
Policy (3435)
Tag
Academia (472)
Africa (129)
Alliances (7278)
Alzheimer's disease (120)
Approvals (1693)
Arizona (9)
Artificial intelligence (21)
Asia (3844)
Australia (796)
Bankruptcy (17)
Best Places to Work (1743)
Biotechnology (13)
C2C Services and Suppliers (6408)
California (250)
Canada (152)
Cancer (52)
Career advice (746)
Career pathing (9)
Cell therapy (14)
China (8)
Clinical research (6139)
Collaboration (43)
Connecticut (12)
COVID-19 (337)
Cystic fibrosis (12)
Data (57)
Diabetes (6)
Diagnostics (902)
Diversity, equity & inclusion (8)
Drug discovery (6)
Earnings (6463)
Employer branding (7)
Employer resources (34)
Europe (10955)
Events (8547)
Executive appointments (17)
FDA (1727)
Florida (25)
Funding (19)
Gene therapy (12)
GLP-1 (40)
Government (517)
Healthcare (2307)
Hotbed/Location (48175)
Illinois (21)
Indiana (12)
Infectious disease (342)
Inflammatory bowel disease (15)
Interviews (178)
IPO (1994)
Job creations (277)
Job search strategy (598)
Layoffs (31)
Legal (570)
Lung cancer (12)
Management (12)
Manufacturing (11)
Maryland (42)
Massachusetts (156)
Medical device (1236)
Medtech (1236)
Mergers & acquisitions (1830)
Metabolic disorders (21)
Minnesota (13)
Neuroscience (134)
New Jersey (67)
New York (63)
NextGen Class of 2024 (724)
Non-profit (532)
North Carolina (43)
Northern California (120)
Obesity (10)
Ohio (18)
Opinion (32)
Patents (12)
Pennsylvania (41)
People (5711)
Phase I (1829)
Phase II (2678)
Phase III (2127)
Pipeline (14)
Policy (8)
Postmarket research (287)
Preclinical (934)
Press Release (9)
Radiopharmaceuticals (22)
Rare diseases (19)
Real estate (532)
Recruiting (20)
Regulatory (2435)
Research institute (358)
Resumes & cover letters (245)
South America (153)
Southern California (108)
Startups (486)
Texas (19)
United States (878)
Vaccines (48)
Virginia (7)
Washington State (45)
Date
Today (1)
Last 7 days (81)
Last 30 days (284)
Last 365 days (4009)
2024 (3008)
2023 (4626)
2022 (5922)
2021 (6683)
2020 (6593)
2019 (5791)
2018 (4324)
2017 (3545)
2016 (3503)
2015 (3617)
2014 (2500)
2013 (2073)
2012 (2280)
2011 (2602)
2010 (2307)
69,391 Results for "applied biocode".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Applied BioCode Announces Retirement of CEO Chris Bernard
Applied BioCode announced the retirement of Chris Bernard as Chief Executive Officer.
March 21, 2024
·
3 min read
Biotech Beach
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only
Applied BioCode now offers STI + Resistance Panel on the BioCode® MDx-3000 system for research use only (RUO).
April 15, 2024
·
4 min read
Biotech Beach
Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use
Applied BioCode now offers Fungal Panel on the BioCode® MDx-3000 system for research use only.
June 12, 2023
·
4 min read
Biotech Beach
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
The Bruker Applied Mass Spectrometry Division is showcasing some of its latest innovations at ASMS 2024.
June 3, 2024
·
4 min read
Business
Applied BioCode Appoints Industry Veteran Chris Bernard as Chief Executive Officer
Applied BioCode announced today that Chris Bernard has been appointed as their new Chief Executive Officer (CEO).
March 24, 2022
·
4 min read
Pharm Country
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
Applied DNA Sciences, Inc. announced that its molecular diagnostics subsidiary, Applied DNA Clinical Labs, LLC, will utilize the GenXys Health Care Systems suite of clinical decision support software for interpretation and reporting of ADCL’s New York State Department of Health-approved TR8™ pharmacogenomic test.
June 18, 2024
·
5 min read
Deals
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on May 9, 2024, it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
May 10, 2024
·
3 min read
Pharm Country
Applied DNA Announces Pricing of $12 Million Public Offering
Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, announced the pricing of a public offering with gross proceeds to the Company expected to be approximately $12.0 million, before deducting placement agent fees and other estimated expenses payable by the Company.
May 28, 2024
·
5 min read
FDA
Applied BioCode Obtains Emergency Use Authorization for CoV-2 Flu Plus Assay
Applied BioCode announced today that it has received Emergency Use Authorization (EUA) from the US FDA for its BioCode® CoV-2 Flu Plus Assay.
December 16, 2021
·
3 min read
Pharm Country
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced that the New York State Department of Health (“NYSDOH”) approved the Company’s TR8™ PGx (“TR8") pharmacogenomic (PGx) testing service.
June 13, 2024
·
5 min read
1 of 6,940
Next